JNCCN Names New Editor-in-Chief
FORT WASHINGTON, Pa., July 10, 2008 — The Journal of the National Comprehensive Cancer Network (JNCCN) has named Harold J. Burstein, MD, PhD, as its new editor-in-chief. Dr. Burstein will lead and set the direction of the journal as well as serve as the ambassador for JNCCN in the oncology community.
Dr. Burstein is a medical oncologist specializing in the treatment of breast cancer at the Dana-Farber Cancer Institute in Boston and an Associate Professor of Medicine at Harvard Medical School. A recognized leader in breast cancer care and clinical research, Dr. Burstein serves as member of several national committees, including the NCCN Breast Cancer Guidelines Panel.
JNCCN is a peer-reviewed, indexed medical journal providing the latest information about optimal clinical practices, oncology outcomes, and new research initiatives. It is currently ranked seventh in readership among the top oncology publications, according to FOCUS, a leading readership-measurement company for medical journals.
“The appointment of Dr. Burstein as the new Editor-in-Chief of JNCCN will assure that the journal will further increase and enhance its scientific and clinical content, readership and esteem in the world of oncology,” said Bill McGivney, PhD, CEO of the NCCN.
JNCCN is a controlled circulation publication distributed to more than 20,000 oncologic subspecialists, including medical and radiation oncologists, hematologists, oncologic surgeons, advanced practice nurses, etc. More information about the journal can be found at www.nccn.org.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
- City of Hope Comprehensive Cancer Center
- Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
- Duke Cancer Institute
- Fox Chase Cancer Center
- Huntsman Cancer Institute at the University of Utah
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Mayo Clinic Cancer Center
- Memorial Sloan Kettering Cancer Center
- Moffitt Cancer Center
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- Roswell Park Cancer Institute
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
- Stanford Cancer Institute
- University of Alabama at Birmingham Comprehensive Cancer Center
- UC San Diego Moores Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
- University of Colorado Cancer Center
- University of Michigan Comprehensive Cancer Center
- The University of Texas MD Anderson Cancer Center
- University of Wisconsin Carbone Cancer Center
- Vanderbilt-Ingram Cancer Center
- Yale Cancer Center/Smilow Cancer Hospital